Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial

Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The completed Phase 3 INBUILD trial record is available, including its study design and outcomes, eligibility criteria, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-07T13:35:28.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:18:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T14:03:09.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:54:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The 403 error page footer now shows site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:55:07.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.7.0' was added to the page, indicating the latest version of the study record. This update reflects the page’s revision history.
    Difference
    17%
    Check dated 2026-09-19T18:59:21.000Z thumbnail image

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.